Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Exclusion Criteria

• •Patients with a history of any previous cytotoxic therapy or radionuclide therapy (such as rhenium, strontium, or samarium)
• •Patients may not be receiving any other investigational agents
• •Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
• •Patients receiving renal dialysis
• •Patients with significant pulmonary disease who have received chronic or pulse steroid therapy within the last 3 months prior to randomization will be excluded
• •Patients who have known hypersensitivity to any of the AndroGel ingredients, including testosterone that is chemically synthesized from soy